1. Scrip
  2. >>Business

India Steps Up Scrutiny After Chinese API Prices, Military Tensions Rise

Drug Shortages Not Expected In The Short-Term

 
• By Vibha Ravi

A recent military skirmish with China and a 35-40% average increase in prices of drug raw materials has seen India step up scrutiny of imports from the country. While the industry is seeking a hike in domestic formulations prices, product shortages are not expected in the short term.

China and India flags
Political Posturing Or Business Troubles? • Source: Shutterstock

India’s customs department recently stepped up its scrutiny of pharmaceutical raw materials imported from China after several, including those for drugs such as paracetamol and antibiotics, saw 35-40% average price increases, and a military face-off with China led to calls for the rejection of goods manufactured in the country.

After a hand-to-hand skirmish between Indian and Chinese soldiers on 15 June led to fatalities, the Indian government banned 59 Chinese-owned apps, including TikTok and WeChat. While no official announcements...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip